Momordin Ic targets SREBP1 to disrupt lipid homeostasis and trigger synergistic apoptosis-ferroptosis in triple-negative breast cancer
{{output}}
Background: Triple-negative breast cancer (TNBC) constitutes a clinically challenging disease subtype characterized by high metastatic potential and unsatisfactory treatment outcomes. Developing innovative pharmacological interve... ...
